Southern California Manufacturer Launches NUTRILINQ, the First Science-Backed Supplement System to Help GLP-1 Users Experiencing Unwanted Side-Effects from Rapid Weight Loss | PR Newswire [Video]

Research-driven supplement system aims to address side effects and enhance outcomes for millions using popular weight loss drugs

, /PRNewswire/ — In a landmark development for the rapidly growing GLP-1 weight loss market, Kelker Pharma, Inc., a manufacturer for many leading dietary supplement brands, today announced the launch of its first branded nutritional supplement system to promote better health and ease the discomforts from the use of GLP-1 medications. The system is called NUTRILINQ™ (www.nutrilinq.com). This comprehensive, physician-formulated nutritional support system is the first of its kind designed to complement GLP-1 receptor agonist medications such as Ozempic^®, Wegovy^®, and Mounjaro^®.

As the use of GLP-1 medication skyrockets in the United States, NUTRILINQ™ emerges as a critical, science-driven solution to address the nutritional challenges faced by patients using the popular weight loss drugs. NUTRILINQ™ is the result of extensive research and clinical expertise, developed to meet …